chr19-1228413-AAAGCTTGGG-A
Position:
Variant summary
Our verdict is Benign. Variant got -10 ACMG points: 0P and 10B. BP6_ModerateBS1BS2
The NM_000455.5(STK11):c.*846_*854delGAAGCTTGG variant causes a splice region change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0308 in 225,774 control chromosomes in the GnomAD database, including 173 homozygotes. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Genomes: 𝑓 0.029 ( 118 hom., cov: 32)
Exomes 𝑓: 0.034 ( 55 hom. )
Consequence
STK11
NM_000455.5 splice_region
NM_000455.5 splice_region
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 2.35
Genes affected
STK11 (HGNC:11389): (serine/threonine kinase 11) The protein encoded by this gene is a serine/threonine kinase that regulates cell polarity and energy metabolism and functions as a tumor suppressor. Mutations in this gene have been associated with the autosomal dominant Peutz-Jeghers syndrome, as well as with skin, pancreatic, and testicular cancers. [provided by RefSeq, May 2022]
CBARP (HGNC:28617): (CACN subunit beta associated regulatory protein) Predicted to enable transmembrane transporter binding activity. Predicted to be involved in negative regulation of calcium ion-dependent exocytosis and negative regulation of voltage-gated calcium channel activity. Predicted to be located in synaptic vesicle membrane. Predicted to be integral component of membrane. Predicted to be active in plasma membrane. Predicted to colocalize with growth cone and secretory granule. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -10 ACMG points.
BP6
Variant 19-1228413-AAAGCTTGGG-A is Benign according to our data. Variant chr19-1228413-AAAGCTTGGG-A is described in ClinVar as [Likely_benign]. Clinvar id is 328247.Status of the report is criteria_provided_single_submitter, 1 stars.
BS1
Variant frequency is greater than expected in population nfe. gnomad4 allele frequency = 0.0294 (4477/152282) while in subpopulation NFE AF= 0.0486 (3305/68000). AF 95% confidence interval is 0.0472. There are 118 homozygotes in gnomad4. There are 2028 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High AC in GnomAd4 at 4477 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
STK11 | NM_000455.5 | c.*846_*854delGAAGCTTGG | splice_region_variant | 10/10 | ENST00000326873.12 | NP_000446.1 | ||
CBARP | NM_001393918.1 | c.*757_*765delCCCAAGCTT | 3_prime_UTR_variant | 10/10 | ENST00000650044.2 | NP_001380847.1 | ||
STK11 | NM_000455.5 | c.*846_*854delGAAGCTTGG | 3_prime_UTR_variant | 10/10 | ENST00000326873.12 | NP_000446.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
STK11 | ENST00000326873.12 | c.*846_*854delGAAGCTTGG | splice_region_variant | 10/10 | 1 | NM_000455.5 | ENSP00000324856.6 | |||
STK11 | ENST00000585748.3 | c.*846_*854delGAAGCTTGG | splice_region_variant | 12/12 | 3 | ENSP00000477641.2 | ||||
CBARP | ENST00000650044 | c.*757_*765delCCCAAGCTT | 3_prime_UTR_variant | 10/10 | NM_001393918.1 | ENSP00000497208.1 | ||||
STK11 | ENST00000326873.12 | c.*846_*854delGAAGCTTGG | 3_prime_UTR_variant | 10/10 | 1 | NM_000455.5 | ENSP00000324856.6 | |||
STK11 | ENST00000585748.3 | c.*846_*854delGAAGCTTGG | 3_prime_UTR_variant | 12/12 | 3 | ENSP00000477641.2 |
Frequencies
GnomAD3 genomes AF: 0.0294 AC: 4477AN: 152168Hom.: 118 Cov.: 32
GnomAD3 genomes
AF:
AC:
4477
AN:
152168
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.0337 AC: 2479AN: 73492Hom.: 55 AF XY: 0.0345 AC XY: 1175AN XY: 34030
GnomAD4 exome
AF:
AC:
2479
AN:
73492
Hom.:
AF XY:
AC XY:
1175
AN XY:
34030
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0294 AC: 4477AN: 152282Hom.: 118 Cov.: 32 AF XY: 0.0272 AC XY: 2028AN XY: 74464
GnomAD4 genome
AF:
AC:
4477
AN:
152282
Hom.:
Cov.:
32
AF XY:
AC XY:
2028
AN XY:
74464
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
22
AN:
3478
ClinVar
Significance: Likely benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Peutz-Jeghers syndrome Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jun 14, 2016 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at